Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV000851613 | SCV000899365 | pathogenic | Hereditary factor IX deficiency disease | 2019-02-01 | criteria provided, single submitter | research | |
ARUP Laboratories, |
RCV001701721 | SCV004565013 | pathogenic | not provided | 2023-03-31 | criteria provided, single submitter | clinical testing | The F8 c.6956C>T; p.Pro2319Leu variant (rs137852472), also known as Pro2300Leu in traditional nomenclature, is reported in the literature in numerous individuals affected with mild-to-moderate hemophilia A (Higuchi 1991, see link to F8 database). This variant is absent from general population databases (Exome Variant Server, Genome Aggregation Database), indicating it is not a common polymorphism. The proline at codon 2319 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.874). Additionally, other variants at this codon (c.6955C>T, p.Pro2319Ser; c.6956C>G, p.Pro2319Arg) have been reported in individuals with hemophilia A and are considered disease-causing (see link to F8 database). Based on available information, the p.Pro2319Leu variant is considered to be pathogenic. References: Link to F8 database: https://f8-db.eahad.org/ Higuchi M et al. Molecular characterization of mild-to-moderate hemophilia A: detection of the mutation in 25 of 29 patients by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8307-11. PMID: 1924291. |
OMIM | RCV000011045 | SCV000031272 | pathogenic | Hereditary factor VIII deficiency disease | 1991-10-01 | no assertion criteria provided | literature only | |
Genome Diagnostics Laboratory, |
RCV001701721 | SCV001931190 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001701721 | SCV001954481 | pathogenic | not provided | no assertion criteria provided | clinical testing |